Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM in ALS Patients
Recruiting
- Conditions
- amyotrophic lateral sclerosis (ALS)
- Registration Number
- jRCT1031230719
- Lead Sponsor
- Hitonowa Medical Seta Yasuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- patients who visited our clinic between January 1, 2022 and November 30, 2023 and have been diagnosed with ALS
- male and female patients aged between 16 and 90 years old
- ALSFRS-R score of 12 or more at the time of initial visit
Exclusion Criteria
- Patients who have a tracheostomy at the time of visit.
- Patients who have expressed their refusal to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - Adverse Events
- Secondary Outcome Measures
Name Time Method ALSFRS-R score change check the amount and rate of change in each ALSFRS-R score and the total ALSFRS-R score
respiratory function test respiratory function test
grip strength grip strength